Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
49.12
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Feb 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
292,835
Open
49.12
Bid (Size)
48.62 (300)
Ask (Size)
48.66 (500)
Prev. Close
49.12
Today's Range
49.12 - 49.12
52wk Range
43.08 - 93.80
Shares Outstanding
N/A
Dividend Yield
2.38%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
HIMS Stock Plunges 8 Straight Days: Is The GLP-1 Fallout Already Priced In?
↗
Today 3:30 EST
Via
Stocktwits
Viking Therapeutics: The Under‑the‑Radar GLP‑1 Contender Growth Hunters Can't Ignore
↗
Today 1:35 EST
This stock has been known to soar after good news.
Via
The Motley Fool
Performance
YTD
-6.2%
-6.2%
1 Month
-17.9%
-17.9%
3 Month
-0.1%
-0.1%
6 Month
-1.3%
-1.3%
1 Year
-41.5%
-41.5%
More News
Read More
Thinking About Investing in GLP-1 Stocks? Here Are 3 Things You Need to Know
↗
February 10, 2026
Via
The Motley Fool
AstraZeneca Signals a New Era in Obesity Care: Earnings Report Teases Oral GLP-1 Powerhouse
February 10, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
Hoth Therapeutics's GDNF Treatment Shows Superior Efficacy Over Wegovy, Ozempic In Preclinical Trial
↗
February 10, 2026
Via
Stocktwits
Could Eli Lilly Turn Today's GLP‑1 Obesity Boom Into Multi‑Decade, Millionaire‑Maker Gains?
↗
February 10, 2026
Via
The Motley Fool
Stock Market Today, Feb. 9: Hims & Hers Health Drops 16% on Novo Nordisk Lawsuit
↗
February 09, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Lawsuit
Stocks
Hims & Hers Collapses After FDA Vows to Restrict Copycat GLP-1 Pill. Is the Stock Toast?
↗
February 09, 2026
Via
The Motley Fool
Topics
Intellectual Property
Lawsuit
Novo Nordisk vs. Eli Lilly: What's the Better Long-Term Investment?
↗
February 09, 2026
Via
The Motley Fool
Topics
Intellectual Property
Why Novo Nordisk Stock Just Popped
↗
February 09, 2026
Via
The Motley Fool
Topics
Intellectual Property
Lawsuit
Why Hims & Hers Stock Just Got Destroyed
↗
February 09, 2026
Via
The Motley Fool
Topics
Lawsuit
The GLP-1 Gold Rush Hits a Wall: Novo Nordisk Sues Hims & Hers as FDA Crackdown Triggers 20% Stock Crash
February 09, 2026
Via
MarketMinute
Topics
Intellectual Property
Lawsuit
FDA Says Novo's Wegovy Pill TV Advertisement Is Misleading: NVO Stock Pares Gains
↗
February 09, 2026
Via
Stocktwits
Topics
Lawsuit
Why Eli Lilly Stock Just Popped
↗
February 09, 2026
Via
The Motley Fool
Topics
Lawsuit
The GLP-1 Gold Rush Hits a Wall: Hims & Hers Shares Crater After Abrupt Oral Wegovy U-Turn
February 09, 2026
Via
MarketMinute
Topics
Earnings
Intellectual Property
Novo Nordisk Sues Hims & Hers Over Compounded Wegovy, Calls For Permanent Sales Ban: HIMS Stock Tanks
↗
February 09, 2026
Via
Stocktwits
Topics
Intellectual Property
Lawsuit
HIMS Stock In Turmoil: Retail Bulls Bet On Rebound, Skeptics See Bloodbath After Compounded Weight-Loss Pill Halt
↗
February 08, 2026
Via
Stocktwits
Topics
Intellectual Property
Law Enforcement
Novo Nordisk Plunges Nearly 15% After Earnings. Here's What Investors Need to Know.
↗
February 08, 2026
Via
The Motley Fool
Medicare Changes in 2026 Every Retiree Needs to Know: The Good, the Bad, and the Ugly
↗
February 08, 2026
Via
The Motley Fool
Topics
Economy
Government
Retirement
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
↗
February 07, 2026
Via
The Motley Fool
Eli Lilly Booms, Then Busts: Stellar Guidance vs Hims Undercut
↗
February 06, 2026
Via
MarketBeat
HIMS Stock Slumps After-Hours On Regulatory Scrutiny On Heels Of Compounded Wegovy Pill Launch
↗
February 06, 2026
Via
Stocktwits
Eli Lilly Projects Record $80B-$83B Revenue for 2026 as Metabolic Franchise Decouples from Competition
February 06, 2026
Via
MarketMinute
Topics
Earnings
Economy
Eli Lilly vs Novo Nordisk: The 1 Figure Investors Shouldn't Ignore
↗
February 06, 2026
Via
The Motley Fool
The $49 Disruptor: Hims & Hers Ignites a Brutal Price War in the Weight-Loss Drug Market
February 06, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
Law Enforcement
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 49.12
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 02/10/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.